DS
CYNA

David Shaw’s CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) CYNA Stock Holding History

David Shaw’s Portfolio CYNA Stock Details CYNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-13,511
Closed -$209K – 4015
2015
Q4 		$209K Buy
+13,511
New +$205K ﹤0.01% 3541

Other funds holding CYNA

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

David Shaw's CYNA Position: Q1 2016 in Review

David Shaw sold out of CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) in Q1 2016, closing a stake of 13,511 shares — an estimated $209K sold.

David Shaw first reported a position in CYNA in Q4 2015 and held it in 1 quarter. The position peaked at $209K in Q4 2015. 31 funds tracked by Wall St. Rank hold CYNA as of Q1 2016.

  • David Shaw reported no remaining CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position as of Q1 2016 after selling out during the quarter.
  • David Shaw sold 13,511 CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) shares in Q1 2016, an estimated $209K.
  • David Shaw first reported a position in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) in Q4 2015 and held it in 1 quarter.
  • David Shaw's CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position peaked at $209K in Q4 2015.
  • 31 funds tracked by Wall St. Rank held CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) as of Q1 2016.

Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.